{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:23:37Z","timestamp":1781324617359,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR Nottingham Biomedical Research Centre [IS-BRC-1215-20003]"],"award-info":[{"award-number":["NIHR Nottingham Biomedical Research Centre [IS-BRC-1215-20003]"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-2017-08-ST2-006"],"award-info":[{"award-number":["RP-2017-08-ST2-006"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR Oxford Health Biomedical Research Centre [BRC-1215-20005]"],"award-info":[{"award-number":["NIHR Oxford Health Biomedical Research Centre [BRC-1215-20005]"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antidepressants may be used to manage a number of conditions in children and young people including depression, anxiety, and obsessive-compulsive disorder. UK guidelines for the treatment of depression in children and young people recommend that antidepressants should only be initiated following assessment and diagnosis by a child and adolescent psychiatrist. The aim of this study was to summarise visits to mental health specialists and indications recorded around the time of antidepressant initiation in children and young people in UK primary care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study used linked English primary care electronic health records and Hospital Episode Statistics secondary care data. The study included 5\u201317-year-olds first prescribed antidepressants between January 2006 and December 2017. Records of visits to paediatric or psychiatric specialists and potential indications (from a pre-specified list) were extracted. Events were counted if recorded less than 12\u2009months before or 6\u2009months after the first antidepressant prescription. Results were stratified by first antidepressant type (all, selective serotonin reuptake inhibitors (SSRIs), tricyclic and related antidepressants) and by age group (5\u201311\u2009years, 12\u201317\u2009years).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 33,031 5\u201317-year-olds were included. Of these, 12,149 (37%) had a record of visiting a paediatrician or a psychiatric specialist in the specified time window. The majority of recorded visits (7154, 22%) were to paediatricians. Of those prescribed SSRIs, 5463\/22,130 (25%) had a record of visiting a child and adolescent psychiatrist. Overall, 17,972 (54%) patients had a record of at least one of the pre-specified indications. Depression was the most frequently recorded indication (12,501, 38%), followed by anxiety (4155, 13%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results suggest many children and young people are being prescribed antidepressants without the recommended involvement of a relevant specialist. These findings may justify both greater training for GPs in child and adolescent mental health and greater access to specialist care and non-pharmacological treatments. Further research is needed to explore factors that influence how and why GPs prescribe antidepressants to children and young people and the real-world practice barriers to adherence to clinical guidelines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-020-01560-7","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T02:02:50Z","timestamp":1588212170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch database"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-020X","authenticated-orcid":false,"given":"Ruth H.","family":"Jack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-0712","authenticated-orcid":false,"given":"Rebecca M.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-3306","authenticated-orcid":false,"given":"Carol","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1083-6744","authenticated-orcid":false,"given":"Chris","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-4121","authenticated-orcid":false,"given":"Richard","family":"Morriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-8321","authenticated-orcid":false,"given":"Roger David","family":"Knaggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-8321","authenticated-orcid":false,"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-8075","authenticated-orcid":false,"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-7283","authenticated-orcid":false,"given":"Julia","family":"Hippisley-Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"1560_CR1","doi-asserted-by":"publisher","first-page":"CD004851","DOI":"10.1002\/14651858.CD004851.pub3","volume":"11","author":"SE Hetrick","year":"2012","unstructured":"Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2012;11:CD004851. https:\/\/doi.org\/10.1002\/14651858.CD004851.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1560_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/da.22329","volume":"32","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015;32(3):149\u201357. https:\/\/doi.org\/10.1002\/da.22329.","journal-title":"Depress Anxiety"},{"key":"1560_CR3","doi-asserted-by":"publisher","first-page":"CD005170","DOI":"10.1002\/14651858.CD005170.pub2","volume":"3","author":"JC Ipser","year":"2009","unstructured":"Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2009;3:CD005170. https:\/\/doi.org\/10.1002\/14651858.CD005170.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1560_CR4","doi-asserted-by":"crossref","unstructured":"NHS Digital. Mental health of children and young people in England, 2017: Emotional Disorders 2018. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/mental-health-of-children-and-young-people-in-england\/2017\/2017#key-facts. Accessed 13 Mar 2020.","DOI":"10.12968\/cypn.2017.12.13"},{"key":"1560_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jad.2016.12.047","volume":"210","author":"J Sarginson","year":"2017","unstructured":"Sarginson J, Webb RT, Stocks SJ, Esmail A, Garg S, Ashcroft DM. Temporal trends in antidepressant prescribing to children in UK primary care, 2000-2015. J Affect Disord. 2017;210:312\u20138. https:\/\/doi.org\/10.1016\/j.jad.2016.12.047.","journal-title":"J Affect Disord"},{"key":"1560_CR6","volume-title":"Depression in children and young people: identification and management (clinical guideline NG134)","author":"National Institute for Health and Care Excellence","year":"2019","unstructured":"National Institute for Health and Care Excellence. Depression in children and young people: identification and management (clinical guideline NG134). 2019. https:\/\/www.nice.org.uk\/guidance\/ng134. Accessed 08 Nov 2019."},{"key":"1560_CR7","volume-title":"Finding help: children, young people and families navigating the system to get the mental health support they need","author":"C Rainer","year":"2019","unstructured":"Rainer C, Crellin R. Finding help: children, young people and families navigating the system to get the mental health support they need. London: The Children\u2019s Society; 2019."},{"key":"1560_CR8","volume-title":"Children\u2019s mental health briefing","author":"Children\u2019s Commissioner","year":"2018","unstructured":"Children\u2019s Commissioner. Children\u2019s mental health briefing. London: Children\u2019s Commissioner for England; 2018."},{"key":"1560_CR9","unstructured":"Mise au point - Le bon usage des antid\u00e9presseurs chez l\u2019enfant et l\u2019adolescent. Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9; 2008."},{"issue":"4","key":"1560_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/JCP.0000000000000891","volume":"38","author":"A Revet","year":"2018","unstructured":"Revet A, Montastruc F, Raynaud JP, Baricault B, Montastruc JL, Lapeyre-Mestre M. Trends and patterns of antidepressant use in French children and adolescents from 2009 to 2016: a population-based study in the French health insurance database. J Clin Psychopharmacol. 2018;38(4):327\u201335. https:\/\/doi.org\/10.1097\/JCP.0000000000000891.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"1560_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/acps.12633","volume":"134","author":"I Hartz","year":"2016","unstructured":"Hartz I, Skurtveit S, Hjellvik V, Furu K, Nesvag R, Handal M. Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study. Acta Psychiatr Scand. 2016;134(5):420\u20139. https:\/\/doi.org\/10.1111\/acps.12633.","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"1560_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaac.2018.05.024","volume":"57","author":"RS Sultan","year":"2018","unstructured":"Sultan RS, Correll CU, Zohar J, Zalsman G, Veenstra-VanderWeele J. What\u2019s in a name? Moving to neuroscience-based nomenclature in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2018;57(10):719\u201321. https:\/\/doi.org\/10.1016\/j.jaac.2018.05.024.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1560_CR13","unstructured":"Paediatric Formulary Committee. BNF for Children (online). http:\/\/www.medicinescomplete.com. Accessed 08 Nov 2019."},{"key":"1560_CR14","volume-title":"Generalised anxiety disorder and panic disorder in adults: management (clinical guideline CG113)","author":"National Institute for Health and Care Excellence","year":"2011","unstructured":"National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management (clinical guideline CG113). 2011. https:\/\/www.nice.org.uk\/guidance\/cg113. Accessed 08 Nov 2019."},{"issue":"1","key":"1560_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.21037\/tp.2017.08.05","volume":"7","author":"DR Patel","year":"2018","unstructured":"Patel DR, Feucht C, Brown K, Ramsay J. Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners. Transl Pediatr. 2018;7(1):23\u201335. https:\/\/doi.org\/10.21037\/tp.2017.08.05.","journal-title":"Transl Pediatr"},{"issue":"16","key":"1560_CR16","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1017\/S0033291716002099","volume":"46","author":"A John","year":"2016","unstructured":"John A, Marchant AL, Fone DL, McGregor JI, Dennis MS, Tan JO, et al. Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study. Psychol Med. 2016;46(16):3315\u201327. https:\/\/doi.org\/10.1017\/S0033291716002099.","journal-title":"Psychol Med"},{"issue":"3","key":"1560_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/ebmental-2019-300097","volume":"22","author":"RH Jack","year":"2019","unstructured":"Jack RH, Hollis C, Coupland C, Morriss R, Knaggs RD, Cipriani A, et al. Trends in antidepressant prescriptions in children and young people in England, 1998-2017: protocol of a cohort study using linked primary care and secondary care datasets. Evid Based Ment Health. 2019;22(3):129\u201333. https:\/\/doi.org\/10.1136\/ebmental-2019-300097.","journal-title":"Evid Based Ment Health"},{"key":"1560_CR18","unstructured":"Joint Formulary Committee. British National Formulary (online). http:\/\/www.medicinescomplete.com. Accessed 08 Nov 2019."},{"key":"1560_CR19","volume-title":"NHS Data Model and Dictionary version 3: MAIN SPECIALTY CODE","author":"NHS Digital","year":"2019","unstructured":"NHS Digital. NHS Data Model and Dictionary version 3: MAIN SPECIALTY CODE. 2019. https:\/\/www.datadictionary.nhs.uk\/data_dictionary\/attributes\/m\/main_specialty_code_de.asp. Accessed 08 Nov 2019."},{"key":"1560_CR20","volume-title":"Obsessive-compulsive disorder and body dysmorphic disorder: treatment (clinical guideline CG31)","author":"National Institute for Health and Care Excellence","year":"2005","unstructured":"National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment (clinical guideline CG31). 2005. https:\/\/www.nice.org.uk\/guidance\/cg31. Accessed 08 Nov 2019."},{"key":"1560_CR21","volume-title":"Neuropathic pain in adults: pharmacological management in non-specialist settings (clinical guideline CG173)","author":"National Institute for Health and Care Excellence","year":"2019","unstructured":"National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings (clinical guideline CG173). 2019. https:\/\/www.nice.org.uk\/guidance\/CG173. Accessed 08 Nov 2019."},{"key":"1560_CR22","volume-title":"Attention deficit hyperactivity disorder: diagnosis and management (clinical guideline NG87)","author":"National Institute for Health and Care Excellence","year":"2018","unstructured":"National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (clinical guideline NG87). 2018. https:\/\/www.nice.org.uk\/guidance\/ng87. Accessed 08 Nov 2019."},{"key":"1560_CR23","volume-title":"Self-harm in over 8s: long-term management (clinical guideline 133)","author":"National Institute for Health and Care Excellence","year":"2011","unstructured":"National Institute for Health and Care Excellence. Self-harm in over 8s: long-term management (clinical guideline 133). 2011. https:\/\/www.nice.org.uk\/guidance\/CG133. Accessed 08 Nov 2019."},{"issue":"8","key":"1560_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/1362361317714588","volume":"22","author":"RC Birch","year":"2018","unstructured":"Birch RC, Foley KR, Pollack A, Britt H, Lennox N, Trollor JN. Problems managed and medications prescribed during encounters with people with autism spectrum disorder in Australian general practice. Autism. 2018;22(8):995\u20131004. https:\/\/doi.org\/10.1177\/1362361317714588.","journal-title":"Autism."},{"key":"1560_CR25","doi-asserted-by":"publisher","first-page":"CD004677","DOI":"10.1002\/14651858.CD004677.pub3","volume":"8","author":"K Williams","year":"2013","unstructured":"Williams K, Brignell A, Randall M, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2013;8:CD004677. https:\/\/doi.org\/10.1002\/14651858.CD004677.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1560_CR26","doi-asserted-by":"publisher","first-page":"CD008372","DOI":"10.1002\/14651858.CD008372.pub2","volume":"3","author":"R Hurwitz","year":"2012","unstructured":"Hurwitz R, Blackmore R, Hazell P, Williams K, Woolfenden S. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents. Cochrane Database Syst Rev. 2012;3:CD008372. https:\/\/doi.org\/10.1002\/14651858.CD008372.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"586","key":"1560_CR27","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.3399\/bjgp11X572472","volume":"61","author":"C Mitchell","year":"2011","unstructured":"Mitchell C, Dwyer R, Hagan T, Mathers N. Impact of the QOF and the NICE guideline in the diagnosis and management of depression: a qualitative study. Br J Gen Pract. 2011;61(586):e279\u201389. https:\/\/doi.org\/10.3399\/bjgp11X572472.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"1560_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/s0047279400020341","volume":"16","author":"P Townsend","year":"2009","unstructured":"Townsend P. Deprivation. J Soc Policy. 2009;16(2):125\u201346. https:\/\/doi.org\/10.1017\/s0047279400020341.","journal-title":"J Soc Policy"},{"key":"1560_CR29","volume-title":"Review of the dissemination of health statistics: confidentiality guidance","author":"Office for National Statistics","year":"2006","unstructured":"Office for National Statistics. Review of the dissemination of health statistics: confidentiality guidance. 2006. https:\/\/www.ons.gov.uk\/methodology\/methodologytopicsandstatisticalconcepts\/disclosurecontrol\/healthstatistics. Accessed 08 Nov 2019."},{"key":"1560_CR30","volume-title":"Bedwetting in under 19s (clinical guideline CG111)","author":"National Institute for Health and Care Excellence","year":"2010","unstructured":"National Institute for Health and Care Excellence. Bedwetting in under 19s (clinical guideline CG111). 2010. https:\/\/www.nice.org.uk\/guidance\/cg111. Accessed 08 Nov 2019."},{"key":"1560_CR31","doi-asserted-by":"publisher","unstructured":"Hinrichs S, Owens M, Dunn V, Goodyer I. General practitioner experience and perception of Child and Adolescent Mental Health Services (CAMHS) care pathways: a multimethod research study. BMJ Open. 2012;2(6). https:\/\/doi.org\/10.1136\/bmjopen-2012-001573.","DOI":"10.1136\/bmjopen-2012-001573"},{"key":"1560_CR32","volume-title":"Access to children and young people\u2019s mental health services - 2018","author":"W Crenna-Jennings","year":"2018","unstructured":"Crenna-Jennings W, Hutchinson J. Access to children and young people\u2019s mental health services - 2018. London: Education Policy Institute; 2018."},{"key":"1560_CR33","volume-title":"Early access to mental health support","author":"Children\u2019s Commissioner","year":"2019","unstructured":"Children\u2019s Commissioner. Early access to mental health support. London: Children\u2019s Commissioner for England; 2019."},{"issue":"1","key":"1560_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12888-018-1961-y","volume":"18","author":"RA Maroun","year":"2018","unstructured":"Maroun RA, Thackeray LA, Midgley N. Meaning and medication: a thematic analysis of depressed adolescents\u2019 views and experiences of SSRI antidepressants alongside psychological therapies. BMC Psychiatry. 2018;18(1):374. https:\/\/doi.org\/10.1186\/s12888-018-1961-y.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"1560_CR35","doi-asserted-by":"publisher","first-page":"e33181","DOI":"10.1371\/journal.pone.0033181","volume":"7","author":"LP Wijlaars","year":"2012","unstructured":"Wijlaars LP, Nazareth I, Petersen I. Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). PLoS One. 2012;7(3):e33181. https:\/\/doi.org\/10.1371\/journal.pone.0033181.","journal-title":"PLoS One"},{"issue":"2","key":"1560_CR36","doi-asserted-by":"publisher","first-page":"e020738","DOI":"10.1136\/bmjopen-2017-020738","volume":"8","author":"E Kontopantelis","year":"2018","unstructured":"Kontopantelis E, Stevens RJ, Helms PJ, Edwards D, Doran T, Ashcroft DM. Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study. BMJ Open. 2018;8(2):e020738. https:\/\/doi.org\/10.1136\/bmjopen-2017-020738.","journal-title":"BMJ Open"},{"key":"1560_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jad.2015.03.040","volume":"180","author":"T Kendrick","year":"2015","unstructured":"Kendrick T, Stuart B, Newell C, Geraghty AW, Moore M. Changes in rates of recorded depression in English primary care 2003-2013: time trend analyses of effects of the economic recession, and the GP contract quality outcomes framework (QOF). J Affect Disord. 2015;180:68\u201378. https:\/\/doi.org\/10.1016\/j.jad.2015.03.040.","journal-title":"J Affect Disord"},{"issue":"8","key":"1560_CR38","doi-asserted-by":"publisher","first-page":"e028201","DOI":"10.1136\/bmjopen-2018-028201","volume":"9","author":"PA Tiffin","year":"2019","unstructured":"Tiffin PA, Mediavilla JL, Close H, Kasim AS, Welsh P, Paton LW, et al. What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study. BMJ Open. 2019;9(8):e028201. https:\/\/doi.org\/10.1136\/bmjopen-2018-028201.","journal-title":"BMJ Open"},{"issue":"2","key":"1560_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00127-016-1306-4","volume":"52","author":"B Mars","year":"2017","unstructured":"Mars B, Heron J, Kessler D, Davies NM, Martin RM, Thomas KH, et al. Influences on antidepressant prescribing trends in the UK: 1995-2011. Soc Psychiatry Psychiatr Epidemiol. 2017;52(2):193\u2013200. https:\/\/doi.org\/10.1007\/s00127-016-1306-4.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01560-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01560-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01560-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:02:04Z","timestamp":1694066524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01560-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01560-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study used anonymised data provided by QResearch and NHS Digital. The project has been reviewed in accordance with the QResearch agreement with East Midlands Derby Research Ethics Committee [reference 18\/EM\/0400].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CH was the chair of the NICE guideline for psychosis in children and young people (CG155) and a member of the NICE ADHD Guideline update committee (NG87).SC has received honoraria for talks\/lectures from the Association for Child and Adolescent Mental Health (ACAMH), British Association of Psychopharmacology (BAP), Canadian ADHD Alliance Resource (CADDRA), and Healthcare Convention.JHC is a professor of clinical epidemiology and general practice at the University of Oxford and co-director of QResearch\u00ae\u2014a not-for-profit organisation which is a joint partnership between the University of Oxford and Egton Medical Information Systems (the leading commercial supplier of IT for 60% of general practices in the UK). JHC was also a paid director of ClinRisk Ltd. which produces open and closed source software to ensure the reliable and updatable implementation of clinical risk equations within clinical computer systems to help improve patient care.RHJ, RMJ, CC, DB, RM, RDK, and AC declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}